Company profile
Ncimb Limited
NCIMB | Microbiology | Analytical Services | Biomaterial Storage
Ncimb Limited is a UK company with status active founded in 1982 based in Scotland.
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Second Filing Of Confirmation Statement With Made Up Date
Confirmation-statementRP04CS01 | Transaction MzQzNDc1NzQ1N2FkaXF6a2N4
Published 06 Sep 2024 09:17
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQzNDYyNzI5OGFkaXF6a2N4
Published 05 Sep 2024 10:49
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzM1MTg3MDYxNWFkaXF6a2N4 | Paper/PDF filed
Published 06 Sep 2024 09:16
Legacy
Annual-return363S | Transaction MTMwODA2MDQ0YWRpcXprY3g
Published 12 Sep 2024 06:16
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction NDkwMjEzNzNhZGlxemtjeA
Published 12 Sep 2024 05:58
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction MTE0MzAyOTAwYWRpcXprY3g
Published 12 Sep 2024 05:58
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction MTIxNzYwMzE0YWRpcXprY3g
Published 12 Sep 2024 06:07
Legacy
Accounts Analysed225(1) | Transaction MTQ3NzM4NDU1YWRpcXprY3g
Published 12 Sep 2024 05:58
Legacy
Annual-return363A | Transaction ODQxNDYwNzBhZGlxemtjeA
Published 12 Sep 2024 05:59
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction MTMzMDc3NzgzYWRpcXprY3g
Published 12 Sep 2024 05:58
Legacy
Annual-return363 | Transaction MTE5MTkxMDUyYWRpcXprY3g
Published 12 Sep 2024 05:59
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction MzYxMDkwMjNhZGlxemtjeA
Published 12 Sep 2024 05:58
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction OTc3MzI2NDRhZGlxemtjeA
Published 12 Sep 2024 05:58
Legacy
Annual-return363 | Transaction MTQ5MTg5NDE5YWRpcXprY3g
Published 12 Sep 2024 05:58
Legacy
Annual-return363 | Transaction MTE2MzUxMzA5YWRpcXprY3g
Published 12 Sep 2024 06:06
Accounts With Accounts Type Full
Accounts AnalysedAA | Transaction MTE2MDE2MTY3YWRpcXprY3g
Published 12 Sep 2024 05:59
Legacy
Annual-return363 | Transaction Nzc3NjI2MjVhZGlxemtjeA
Published 12 Sep 2024 05:59
Legacy
Annual-return363 | Transaction MTA4Njc5ODgwYWRpcXprY3g
Published 12 Sep 2024 06:07
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Superior synbiotics for healthy ageing
1 Oct 2024 to 31 Mar 2026
Scottish biotechnology company NCIMB, is teaming up with the Rowett Institute, University of Aberdeen to develop novel designer probiotics targeting gut health. NCIMB are microbiology experts and manage the UK's largest collection of bacterial strains. The Rowett Institute has expertise in the gut microbiome and the interactions between microbes and inter...
Development and Manufacture of Novel Cyclodextrins
1 May 2024 to 30 Apr 2025
Cyclodextrins are cyclic oligosaccharides produced from starch hydrolysis using bacterial enzymes. They are safe, natural products that trap, solubilise, and stabilise a range of bioactive molecules. They are highly selective with applications in food, food supplements, personal care, pharmaceuticals, agrochemicals, paints, and surface coatings. The marke...
Harnessing the power of engineering biology to develop and translate novel live biotherapeutics
1 Feb 2024 to 31 Jan 2025
In this exciting collaborative project, NCIMB, an established Scottish biotechnology company, is teaming up with GitLife Biotech (GLB), a spinout from Newcastle University. The partners aim to develop new innovative products and services using groundbreaking Engineering Biology protocols. The proposed project centres around the development of a new class ...
Neutralising the harmful effects of dental biofilms by bacterial replacement therapy
1 Jun 2016 to 31 May 2017
Dental caries is a widespread oral disease that is costly for health services to treat, and causes pain and loss of teeth to those affected. It is caused by production of acid by oral bacteria in biofilms on the teeth and gums commonly known as dental plaque. Brushing teeth can reduce this problem, but many people do not do so regularly or thoroughly. Thi...
Management and control of biofilms in the oil and gas industry
1 Mar 2016 to 28 Feb 2017
Microbial biofilms can cause significant economic and environmental issues in oilfield systems from reduction in flow rates, souring of crude oil and contribution to corrosion of concrete and metal surfaces. Current methods for the control of biofilms in these situations include the use of chemical biocides which are expensive and can lead to environmenta...
The Robert Gordon University and NCIMB Limited
1 Jan 2016 to 31 Dec 2018
To initiate exploitation of the NCIMB culture collection by developing knowledge and processes for screening Streptomyces sp. for novel natural commercial products and the development of new product lines.
Identification of novel probiotic microorganisms for improved gut function
1 Jan 2014 to 31 Dec 2014
Probiotics are live microorganisms which when taken in adequate amounts confer health benefits. Changing diets and lifestyles have seen an increase in diet-related health conditions which probiotics acting as novel functional food ingredients can help. There are many probiotic species but the majority of commercial products are restricted to the Lactobaci...
Optimising energy production from anaerobic digestion using molecular microbial monitoring techniques developed for the oil and gas industries
1 Mar 2013 to 30 Jun 2013
This feasibility study will investigate the potential of transferring competency and methods developed for use in the oil industry for the determination of bacterial populations, to the production of renewable energy from wastes and other renewable sources using anaerobic digestion (AD) technology. Improved performance and lowering of associated risks in ...
Accelerated development of industrial microbes using GSA
1 Sep 2012 to 31 Aug 2014
This project addresses a severe limitation of the critical enabling technology required for the successful industrial use of engineered microbes, namely to rapidly achieve efficient production of proteins from heterologous DNA, either as end products in themselves or as enzymes whose concerted action produces other high value products. The project follows...